As part of our commitment to patients, Genzyme is dedicated to protecting the safety and integrity of our products, which are now helping people in every corner of the globe. Worldwide markets for biopharmaceutical products like ours are generally well regulated for the secure delivery of medicines, and we have great trust in the governments and commercial partners who help distribute our therapies.
However, the sheer size of the biopharmaceutical market and increasing patient demand for these therapies can attract criminal individuals and organizations, who seek to profit from world markets by counterfeiting, adulterating, diverting, or stealing pharmaceuticals. Medicines that go through such channels may be altered in ways that make them unstable, ineffective, and even toxic – posing a tremendous threat that could be increasing globally. If such medicines are not identified before they reach patients, patient health can be put at jeopardy.
To protect our patients from the risks of criminally altered or counterfeit products, Genzyme has proactively initiated a security program to safeguard the integrity of our global product supply as it moves through various distribution channels. We have integrated unique identification features into our product packaging to enable accurate verification – a critical step before any treatment is administered to a patient. We also continue to monitor and audit our global distribution network to ensure that proper security protocols and measures are in place. Delivering safe, secure, effective products to patients remains our commitment.
If you have any questions or concerns regarding the integrity of a Genzyme product, we recommend you discuss them with your physician, pharmacist, or other health care professional.
You're also welcome to contact Genzyme Medical Information:
Reporting Side Effects
To help us monitor and assess the ongoing safety of our products, Genzyme encourages patients and their health care providers to alert us about any side effects. You are also encouraged to report negative side effects of prescription medicines directly to the U.S. FDA.
Find out more about reporting side effects
Last Updated: 4/26/2012